| Literature DB >> 23164649 |
Aimin Chen1, Stephani S Kim, Ethan Chung, Kim N Dietrich.
Abstract
BACKGROUND: Heavy metals, such as lead (Pb), mercury (Hg), and cadmium (Cd), are known toxicants, but their associations with the thyroid axis have not been well quantified at U.S. background levels.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23164649 PMCID: PMC3569681 DOI: 10.1289/ehp.1205239
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Blood and urinary Pb, Hg, and Cd levels and TH levels in the NHANES 2007–2008.
| Adolescents | Adults | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| n | Mean | Range | GM | n | Mean | Range | GM | ||
| Metal | |||||||||
| Blood Pb (µg/dL) | 1,009 | 0.93 | 0.18–9.20 | 0.81 | 4,409 | 1.75 | 0.18–33.1 | 1.43 | |
| Total Hg (µg/L) | 1,009 | 0.68 | 0.20–6.98 | 0.47 | 4,409 | 1.62 | 0.20–43.9 | 0.96 | |
| Organic Hg (µg/L) | 1,005 | 0.49 | 0.01–6.73 | 0.21 | 4,404 | 1.31 | 0.01–42.9 | 0.61 | |
| Blood Cd (µg/L) | 1,009 | 0.29 | 0.14–4.70 | 0.21 | 4,409 | 0.55 | 0.14–8.81 | 0.38 | |
| Urinary Cd (µg/g creatinine) | 312 | 0.08 | 0.01–1.60 | 0.07 | 1,455 | 0.34 | 0.02–4.04 | 0.25 | |
| TH | |||||||||
| TT4 (µg/dL) | 1,009 | 7.46 | 1.50–18.50 | 7.34 | 4,409 | 7.63 | 2.00–27.6 | 7.48 | |
| FT4 (ng/dL) | 1,009 | 0.79 | 0.10–1.50 | 0.78 | 4,409 | 0.77 | 0.30–4.80 | 0.76 | |
| TT3 (ng/dL) | 1,009 | 130.37 | 74.00–241.00 | 128.36 | 4,409 | 112.50 | 37.0–632.0 | 110.4 | |
| FT3 (pg/mL) | 1,009 | 3.64 | 2.20–6.00 | 3.61 | 4,409 | 3.21 | 1.90–20.70 | 3.18 | |
| TSH (µIU/mL) | 1,009 | 1.84 | 0.01–280.76 | 1.47 | 4,409 | 2.01 | 0.002–80.97 | 1.60 | |
| Tg (ng/mL) | 1,009 | 10.83 | 0.07–353.56 | 7.64 | 4,409 | 15.62 | 0.07–4461.00 | 9.56 | |
| GM, geometric mean. | |||||||||
Adjusted regression coefficients (95% CIs) of blood and urinary Pb, Hg, and Cd in relation to THs in adolescents.
| Metal | lnTT4 | lnFT4 | lnTT3 | lnFT3 | lnTSH | lnTg |
|---|---|---|---|---|---|---|
| lnBPb | 0.01 (–0.02, 0.04) | 0.01 (–0.01, 0.04) | 0.01 (–0.01, 0.04) | 0.02 (–0.002, 0.04) | –0.05 (–0.18, 0.07) | 0.05 (–0.13, 0.24) |
| lnTotal Hg | –0.02 (–0.04, –0.001)* | 0.005 (–0.01, 0.02) | –0.02 (–0.03, 0.001) | –0.01 (–0.02, –0.003)* | 0.02 (–0.04, 0.08) | –0.05 (–0.20, 0.10) |
| lnOrganic Hg | –0.01 (–0.03, 0.004) | 0.01 (–0.01, 0.02) | –0.01 (–0.02, 0.01) | –0.01 (–0.02, –0.001)* | –0.01 (–0.06, 0.04) | –0.06 (–0.17, 0.04) |
| lnBlood Cd | –0.01 (–0.06, 0.03) | –0.01 (–0.05, 0.04) | –0.01 (–0.03, 0.02) | 0.02 (0.0003, 0.03)* | –0.11 (–0.27, 0.04) | 0.07 (–0.15, 0.28) |
| lnUrinary Cd | –0.0003 (–0.03, 0.03) | 0.04 (0.002, 0.08)* | 0.02 (–0.02, 0.06) | 0.02 (–0.01, 0.04) | –0.03 (–0.24, 0.17) | 0.08 (–0.13, 0.30) |
| Adjusted for age, sex, race/ethnicity, creatinine-adjusted urinary iodine, BMI z–score, and serum cotinine level. *p < 0.05. | ||||||
Adjusted regression coefficients (95% CIs) of blood and urinary Pb, Hg, and Cd in relation to THs in adults.
| Metal | lnTT4 | lnFT4 | lnTT3 | lnFT3 | lnTSH | lnTg |
|---|---|---|---|---|---|---|
| lnBPb | –0.01 (–0.02, 0.01) | 0.01 (–0.01, 0.02) | –0.0004 (–0.02, 0.02) | 0.01 (–0.001, 0.02) | –0.01 (–0.06, 0.04) | 0.01 (–0.03, 0.06) |
| lnTotal Hg | –0.02 (–0.02, –0.01)* | –0.005 (–0.01, 0.004) | –0.03 (–0.04, –0.01)* | –0.01 (–0.02, –0.01)* | 0.004 (–0.02, 0.03) | –0.01 (–0.05, 0.03) |
| lnOrganic Hg | –0.01 (–0.02, –0.004)* | –0.004 (–0.01, 0.001) | –0.02 (–0.03, –0.01)* | –0.01 (–0.01, –0.004)* | 0.01 (–0.01, 0.03) | 0.001 (–0.02, 0.03) |
| lnBlood Cd | 0.005 (–0.01, 0.02) | 0.01 (0.001, 0.02)* | 0.004 (–0.01, 0.02) | 0.0002 (–0.01, 0.01) | –0.02 (–0.07, 0.03) | 0.10 (0.05, 0.16)* |
| lnUrinary Cd | 0.02 (0.001, 0.03)* | 0.01 (–0.01, 0.03) | 0.03 (0.02, 0.05)* | 0.01 (0.002, 0.02)* | –0.04 (–0.09, 0.02) | 0.15 (0.23, 0.25)* |
| Adjusted for age, sex, race/ethnicity, creatinine-adjusted urinary iodine, BMI value, and serum cotinine level. *p < 0.05. | ||||||
Figure 1Estimated thyroid hormone levels according to natural log blood total Hg or urinary Cd exposure quintiles in adults, NHANES 2007–2008. (A) TT4 by blood total Hg quintiles, (B) TT3 by blood total Hg quintiles, (C) TT4 by urinary Cd quintiles, (D) TT3 by urinary Cd quintiles.
Adjusted ORs (95% CIs) of high TgAb (> 4 IU/mL) and high TPOAb (> 9 IU/mL) per unit change in ln metal exposure in adolescents and adults.
| Metal | Adolescentsa | Adultsb | |||
|---|---|---|---|---|---|
| High TgAb | High TPOAb | High TgAb | High TPOAb | ||
| Percent | 4.79 | 6.04 | 5.77 | 8.83 | |
| lnBPb | 0.77 (0.37–1.59) | 1.16 (0.58–2.33) | 1.20 (0.87–1.64) | 1.09 (0.82–1.46) | |
| lnTotal Hg | 1.17 (0.64–2.13) | 1.15 (0.68–1.95) | 0.94 (0.78–1.13) | 0.91 (0.80–1.04) | |
| lnOrganic Hg | 1.29 (0.85–1.96) | 1.06 (0.66–1.72) | 0.95 (0.81–1.11) | 0.96 (0.87–1.06) | |
| lnBlood Cd | 1.18 (0.56–2.51) | 1.44 (0.71–2.95) | 1.09 (0.74–1.60) | 1.14 (0.85–1.51) | |
| lnUrinary Cd | 0.99 (0.49–2.02) | 0.97 (0.41–2.28) | 0.84 (0.47–1.48) | 1.20 (0.75–1.93) | |
| aAdjusted for age, sex, race/ethnicity, creatinine-adjusted urinary iodine, BMI z-score, and serum cotinine level. bAdjusted for age, sex, race/ethnicity, creatinine-adjusted urinary iodine, BMI value, and serum cotinine level. | |||||
Interpretation of the observed association per IQR change in exposure on TH levels.
| Population/metal exposure | IQR (P25 to P75) or LOD/√–2a to P75 | lnP75–lnP25 | Association with THs | Regression estimate for IQR change (95% CI) | Percentage difference in THs (95% CI) for exposure at P75 compared with P25 or LOD/√–2 if > 25% of subjects had exposure < LOD |
|---|---|---|---|---|---|
| Adolescents | |||||
| Total Hg (µg/L) | 0.20a–0.82 | 1.41 | ↓TT4 | –0.03 (–0.05, –0.001) | –2.6 (–5.0, –0.1) |
| ↓FT3 | –0.02 (–0.03, –0.004) | –1.6 (–2.7, –0.4) | |||
| Organic Hg (µg/L) | 0.20a–0.53 | 0.97 | ↓FT3 | –0.01 (–0.02, –0.001) | –0.8 (–1.6, –0.1) |
| Blood Cd (µg/L) | 0.14a–0.25 | 0.58 | ↑FT3 | 0.01 (0.0001, 0.02) | 0.9 (0.01, 1.9) |
| Urinary Cd (µg/g creatinine) | 0.04–0.11 | 1.01 | ↑FT4 | 0.04 (0.002, 0.08) | 4.3 (0.2, 8.5) |
| Adults | |||||
| Total Hg (µg/L) | 0.49–1.80 | 1.30 | ↓TT4 | –0.02 (–0.03, –0.008) | –2.0 (–3.0, –0.8) |
| ↓TT3 | –0.03 (–0.05, –0.02) | –3.3 (–5.0, –1.5) | |||
| ↓FT3 | –0.02 (–0.02, –0.01) | –1.7 (–2.2, –1.2) | |||
| Organic Hg (µg/L) | 0.21–1.39 | 1.89 | ↓TT4 | –0.02 (–0.03, –0.01) | –2.0 (–3.2, –0.8) |
| ↓TT3 | –0.03 (–0.05, –0.01) | –3.2 (–5.2, –1.1) | |||
| ↓FT3 | –0.01 (–0.02, –0.01) | –1.4 (–2.1, –0.7) | |||
| Blood Cd (µg/L) | 0.21–0.61 | 1.07 | ↑FT4 | 0.01 (0.001, 0.02) | 1.0 (0.1, 1.9) |
| ↑Tg | 0.11 (0.06, 0.17) | 11.9 (6.0, 18.1) | |||
| Urinary Cd (µg/g creatinine) | 0.14–0.41 | 1.07 | ↑TT4 | 0.02 (0.001, 0.03) | 1.9 (0.1, 3.6) |
| ↑TT3 | 0.04 (0.02, 0.05) | 3.6 (1.8, 5.4) | |||
| ↑FT3 | 0.01 (0.002, 0.02) | 1.0 (0.2, 1.9) | |||
| ↑Tg | 0.16 (0.07, 0.25) | 17.5 (7.7, 28.3) | |||
| Abbreviations: P75, 75th percentile; P25, 25th percentile. aInstead of first quartile, the interval starts from < LOD (value replaced with LOD divided by the square root of 2) to reflect > 25% participants with exposure < LOD. | |||||